January 28, 2020. Modulim’s VP of R&D Amaan Mazhar will be presenting an invited talk at the Molecular Guided Surgery Conference at Photonics West 2020 held in San Francisco, CA. The talk entitled “Quantitative assessment of lower limb circulation with non-invasive optical imaging”, will be presented in the Advanced Detection Methods Session at 10am on February 1, 2020. The presentation will include a summary of the work done by the Modulim team and their clinical partners to understand circulatory signatures in the foot using Spatial Frequency Domain Imaging (SFDI). Dr. Mazhar will also be chairing a session at the same conference.
Modulim delivers transformative optical solutions that help people live healthier, longer lives. Clarifi, powered by Spatial Frequency Domain Imaging (SFDI) technology, identifies compromised circulation at the point of care through non-contact rapid microvascular assessment of tissue. Clinicians and healthcare systems are empowered by SFDI images to make proactive, data-driven decisions in a multidisciplinary care setting, in order to reduce lower-limb complications caused by diabetes and peripheral arterial disease. Founded by the inventors of SFDI at the University of California Irvine, Modulim is based in Irvine, CA with a team dedicated to delivering powerful healthcare solutions that elevate and standardize health care delivery, while improving patient outcomes. Modulim is backed by Pangaea Ventures, Fresenius Medical Care Ventures, Grey Sky Venture Partners, Mitsubishi Capital, Hamamatsu Photonics, The Cove Fund at UCI Applied Innovation, and Fouse KK.
Clarifi is a registered trademark of Modulated Imaging (dba Modulim).
VP Sales and Marketing